Multimorbidity in older patients with cardiovascular disease

SM Dunlay, AM Chamberlain - Current cardiovascular risk reports, 2016 - Springer
Multimorbidity affects more than two thirds of older individuals and the vast majority of
patients with chronic cardiovascular disease. Patients with multimorbidity have high …

Safe prescribing of non-steroidal anti-inflammatory drugs in patients with osteoarthritis–an expert consensus addressing benefits as well as gastrointestinal and …

C Scarpignato, A Lanas, C Blandizzi, WF Lems… - BMC medicine, 2015 - Springer
Background There are several guidelines addressing the issues around the use of NSAIDs.
However, none has specifically addressed the upper versus lower gastrointestinal (GI) risk …

Glucose-lowering therapy and cardiovascular outcomes in patients with type 2 diabetes mellitus and acute coronary syndrome

A Avogaro, E Bonora, A Consoli… - Diabetes and …, 2019 - journals.sagepub.com
Diabetes is a common comorbidity in patients hospitalized for an acute coronary syndrome
event, and prevalence is increasing. Among patients hospitalized with acute myocardial …

Patterns and temporal trends of comorbidity among adult patients with incident cardiovascular disease in the UK between 2000 and 2014: a population-based cohort …

J Tran, R Norton, N Conrad, F Rahimian, D Canoy… - PLoS …, 2018 - journals.plos.org
Background Multimorbidity in people with cardiovascular disease (CVD) is common, but
large-scale contemporary reports of patterns and trends in patients with incident CVD are …

Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort

M Hall, TB Dondo, AT Yan, MA Mamas… - PLoS …, 2018 - journals.plos.org
Background There is limited knowledge of the scale and impact of multimorbidity for patients
who have had an acute myocardial infarction (AMI). Therefore, this study aimed to determine …

[HTML][HTML] Trends in comorbidity in patients hospitalised for cardiovascular disease

J Buddeke, ML Bots, I van Dis, A Liem… - International journal of …, 2017 - Elsevier
Background We determined trends over time in cardiovascular and non-cardiovascular
comorbidity in patients hospitalised for cardiovascular disease (CVD). Methods The Dutch …

Prevalence of noncardiac multimorbidity in patients admitted to two cardiac intensive care units and their association with mortality

PE Miller, A Thomas, TJ Breen, F Chouairi… - The American journal of …, 2021 - Elsevier
Background Current cardiac intensive care unit (CICU) practice has seen an increase in
patient complexity, including an increase in noncardiac organ failure, critical care therapies …

Integrated Analysis of lncRNA–miRNA–mRNA Regulatory Network in Rapamycin-Induced Cardioprotection against Ischemia/Reperfusion Injury in Diabetic Rabbits

A Samidurai, AL Olex, R Ockaili, D Kraskauskas… - Cells, 2023 - mdpi.com
The inhibition of mammalian target of rapamycin (mTOR) with rapamycin (RAPA) provides
protection against myocardial ischemia/reperfusion (I/R) injury in diabetes. Since …

Coronary artery disease severity and long-term cardiovascular risk in patients with myocardial infarction: a Danish nationwide register-based cohort study

C Özcan, A Deleskog… - European Heart …, 2018 - academic.oup.com
Aim Long-term prognostic impact of coronary artery disease (CAD) severity in stable post-
myocardial infarction (MI) patients is not well known. We examined the impact of CAD …

[HTML][HTML] Association of comorbidities with clinical outcomes in patients after acute myocardial infarction

C Baechli, D Koch, S Bernet, L Gut, U Wagner… - IJC Heart & …, 2020 - Elsevier
Background Multimorbidity becomes more prevalent in patients admitted for acute
myocardial infarction (AMI). We investigated the association of an increasing number of …